Concentrations of amphotericin B in body fluid from patients with AIDS-associated cryptococcal meningitis
10.3760/cma.j.issn.1674-2397.2009.01.011
- VernacularTitle:两性霉素B治疗艾滋病合并隐球菌性脑膜炎患者的药物浓度研究
- Author:
Xianmin MENG
;
Renfang ZHANG
;
Yufang ZHENG
;
Li LIU
;
Li ZHANG
;
Ping DONG
- Publication Type:Journal Article
- Keywords:
Acquired immunodeficiency syndrome;
Amphotericin B;
Cryptococcal meningitis;
Blood;
Cerebrospinal fluid
- From:
Chinese Journal of Clinical Infectious Diseases
2009;2(1):43-46
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the concentrations of amphotericin B in serum and cerebrospinal fluid from patients with AIDS-associated cryptococcal meningitis.Methods Ten patients with AIDS-associated cryptococcal meningitis were enrolled in the study.Blood samples were collected before drug administrated at the 7th.14th and 21 th day after maintenance dose achieved.Cerebrospinal fluid samples were collected from lumbar puncture or taken before intrathecal drug administration at least one week after maintenance dose achieved.The concentrations of amphoteriein B in blood and cerebrospinal fluid samples were determined using RP-HPLC.Results When maintenance doses varied from 25 to 40 mg/d,the blood steady-state trough concentration range of amphotericin B was 1.34-2.27 ms/L,and that of cerebrospinal fluid was 44.0-9 1.7μg/L.Conclusions The concentrations of amphotericin B in the cerebrospinal fluid would be lower than the desired concentration if amphotericin B administrated only through intravenous or integrated with irregular intrathecal administration.It suggests that higher dosage of intravenous injection and regular intrathecal administration should be applied to achieve the desired concentration.
